Evidence map›Paper›PMID 42429621›Full record

ArticlemSphere2026

Genetic control of Group 3 (K96) capsule synthesis and complement resistance in extraintestinal pathogenic

Rachael J David Prince, Rajesh Bogati, Titan Lytle, Andres Collado Silva, Rachael A LeBaron, Tiana Sorge, Michael A Olson, Eric Wilson, David L Erickson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Rachael J David PrinceDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, USA.
Rajesh BogatiDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, USA.
Titan LytleDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, USA.
Andres Collado SilvaDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, USA.
Rachael A LeBaronDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, USA.
Tiana SorgeDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, USA.
Michael A OlsonSnow College, Ephraim, Utah, USA.
Eric WilsonDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, USA.ORCID 0000-0002-7551-2938
David L EricksonDepartment of Microbiology and Molecular Biology, Brigham Young University, Provo, Utah, USA.ORCID 0000-0001-6149-273X

Funding

Investigating virulence functions of mastitis-associated Extraintestinal pathogenic Escherichia coli relevant to human diseaseR15AI159847 · NIAID · BRIGHAM YOUNG UNIVERSITY · PI ERICKSON, DAVID L. · 2022 to 2022
$379k
NIAID NIH HHS R15 AI159847NIAID NIH HHS R15AI159847-01A1
6 · The paper itself

Abstract

Extraintestinal pathogenic

Indexed as

Bacterial CapsulesComplement System ProteinsExtraintestinal Pathogenic Escherichia coliGene Expression Regulation, BacterialAnimalsEscherichia coli InfectionsEscherichia coli ProteinsHumansImmune EvasionMutationVirulenceVirulence FactorsComplement System ProteinsEscherichia coli ProteinsVirulence Factorscapsulecomplement resistanceExPECmastitis-associated E. colioxyRphase variation

Identifiers

PMID42429621
PMCPMC13410964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.